Dedicated clinicians who inform
pharmacy decisions based on
efficacy, evidence and empathy

The mission of the Rx Savings Solutions Pharmacy and Therapeutics (P&T) Committee is to provide safe, quality and cost-effective drug information for RxSS members and clients.

DID YOU KNOW?

Covering more than 17 million members, the RxSS P&T Committee oversees more lives than all but the four largest health plans in the U.S., just behind the Centers for Medicare & Medicaid Services (CMS).

0
Total number of active suggestions
0
Unique products with suggestions
0
Average number of suggestions per product
Members of the Rx Savings Solutions Pharmacy and Therapeutics (P&T) Committee in a conference room sitting around a table
0
Total number of active suggestions
0
Unique products with suggestions
0
Average number of suggestions per product
0
Total number of active suggestions
0
Unique products with suggestions
0
Average number of suggestions per product

MEET THE VOTING MEMBERS

Vice President, Pharmacy
Director of Pharmacy

Director of Pharmacy – Health Plans

Director of Pharmacy Operations

Director, Specialty Pharmacy Solutions
Director of Client Success – Health Plans
Clinical Pharmacist, Sales
Founder & CEO
Assistant Clinical Professor University of California San Francisco Fresno School of Medicine
Director of Compliance

our purpose

The P&T Committee maintains the RxSS database of clinical suggestions to promote safety, efficacy and advance the company mission.
connect icon

ENSURE

Ensure compliance with clinical standards of care using appropriate drug compendia, national guidelines and emerging pharmacological data.

REVIEW

Review new drugs, therapeutic classes, clinical indications, therapeutic advantages and safety information.

EVALUATE

Evaluate outcomes from member prescription change requests and analyze prescriber acceptance/denial rates.

connect icon

ENSURE

Ensure compliance with clinical standards of care using appropriate drug compendia, national guidelines and emerging pharmacological data.

REVIEW

Review new drugs, therapeutic classes, clinical indications, therapeutic advantages and safety information.

EVALUATE

Evaluate outcomes from member prescription change requests and analyze prescriber acceptance/denial rates.

OUR CRITERIA

In addition to peer-reviewed, evidence-based and fully referenced drug compendia, the P&T Committee curates savings suggestions based on one, final litmus test: Would we recommend this to our family?
Maximize safety and limit risk when evaluating the potential savings benefit of a suggested product compared with a current treatment.

Show only suggestions with equivalent efficacy or recommended alternatives.

Limit the risk of member confusion when mapping products with multiple alternatives while also aligning with reasonable standards of care.

What is more likely to increase a member’s adherence—cost or convenience? We show options that check the box for both to help members stay on track with prescribed treatments.

In general, we will suggest any existing clinically appropriate alternative, giving preference to more commonly utilized cost-effective options.

X